Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses
Top Cited Papers
Open Access
- 1 March 2000
- Vol. 100 (5) , 575-585
- https://doi.org/10.1016/s0092-8674(00)80693-5
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- C-type lectin-like domainsPublished by Elsevier ,1999
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999
- Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cellsEuropean Journal of Immunology, 1995
- Distinct binding of T lymphocytes to ICAM‐1, ‐2 or ‐3 upon activation of LFA‐1European Journal of Immunology, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- ICAM‐3, the third LFA‐1 counterreceptor, is a co‐stimulatory molecule for both resting and activated T lymphocytesEuropean Journal of Immunology, 1993
- Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes.The Journal of Experimental Medicine, 1992
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Involvement of the CDw50 molecule in allorecognitionTissue Antigens, 1990
- The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune SystemAnnual Review of Immunology, 1987